News

X‑Chem Licenses Cardiovascular Drug Discovery Program to Bayer Pharma AG

December 17, 2014

WALTHAM, Mass. – December 17, 2014 - X-Chem, Inc., a privately held biotechnology company focused on applying its innovative drug discovery capabilities to the generation of novel small molecule therapeutics,…

News

X‑Chem and Alexion Collaborate to Discover Novel Therapeutic Candidates to Treat Patients with Severe and Ultra-Rare Disorders

December 10, 2014

WALTHAM, MA – December 11th, 2014 – X-Chem, Inc., a biotechnology company focused on the generation of novel small molecule therapeutics using its proprietary DNA-encoded library platform, today announced the…

News

PPD Exercises Option to Acquire Remaining Interest in X‑Chem, Inc.

September 25, 2014

WILMINGTON, N.C. and WALTHAM, Mass.– September 25, 2014 – Pharmaceutical Product Development, LLC (PPD) and X-Chem, Inc. announced today that PPD has exercised its option to acquire the remaining minority…

News

X‑Chem Enters into Multi-Target Collaboration with Pfizer Inc.

June 10, 2014

WALTHAM, Mass. – June 11, 2014 - X-Chem, Inc., a privately held biotechnology company applying its cutting-edge lead discovery capabilities to the generation of novel small molecule therapeutics, today announced…

News

X‑Chem Licenses Epigenetic Drug Discovery Program to Bayer Pharma AG

February 13, 2014

WALTHAM, Mass. – February 13, 2014 - X-Chem, Inc., a privately held biotechnology company focused on applying its innovative drug discovery capabilities to the generation of novel small molecule therapeutics,…

News

X‑Chem First Biotech to Exceed 100 Billion Compounds with its Unique and Proprietary Small Molecule DNA-Encoded Library

February 2, 2014

WALTHAM, MA, USA – February 4, 2014 - X-Chem, Inc., a privately held biotechnology company focused on applying its powerful product engine to the generation of novel small molecule therapeutics,…

News

X‑Chem and PsyBrain Establish Partnership to Discover New Psychiatric Medicines

January 10, 2014

WALTHAM, Mass. – January 10, 2014 - X-Chem, Inc., a privately held biotechnology company focused on applying its innovative drug discovery capabilities to the generation of novel small molecule therapeutics,…